Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gammanorm Pump vs Rapid Push in PID
NCT02180763Phase 4Completed
- Sponsor
- Octapharma
- Start
- Apr 2014
- Primary completion
- Aug 2016
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of human normal immunoglobulin in primary immunodeficiency (PI), sponsored by Octapharma. Started Apr 2014; status: completed.
02
Drugs
human normal immunoglobulin
03
Conditions
primary immunodeficiency (PI)
Beyond the preview
Go deeper on NCT02180763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02180763.